http://r20.rs6.net/on.jsp?a=1104611680166&r=3&c=3c0609d0-9b5d-11e4-94d2-d4ae528440e0&d=1125594227907&ch=e135c5b0-9b64-11e4-952d-d4ae528440e0&ca=25c229a5-bd42-4a1a-b7ef-43fd31be9e4e&o=https://imgssl.constantcontact.com/ui/images1/s.gif

http://img.constantcontact.com/letters/images/sys/S.gif

 

SUMMER 2016

 

http://img.constantcontact.com/letters/images/1101116784221/teenoland_2015T_TheBlend.png

http://img.constantcontact.com/letters/images/1101116784221/teenoland_2015T_Logo.png

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

http://files.constantcontact.com/6af9cff2101/1d0e8c00-e0a5-42ba-891c-32e4062760be.jpg

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

FEATURE

 

FAST INVESTIGATION RESPONSE

 SOLVING TEAM (F.I.R.S.T.): NARROWING TIMEFRAMES TO RESOLVE QUALITY ISSUES

 

http://files.constantcontact.com/6af9cff2101/aa4d1397-c0b8-4e58-826f-9873a90d4a64.jpgPharma Tech Industries recently launched F.I.R.S.T., the Fast Investigation Response Solving Team, to quickly determine the root cause of any quality control deviation that occurs. The group amounts to a dedicated, cross-disciplinary unit that quickly responds to production deviations and, in doing so, shortens typical investigation times.  The ultimate goal, of course, is to best ensure on-time, defect-free delivery of customer projects.  The team is composed of members from a variety of core groups - including Safety, Engineering, Quality, Operation and Facilities - but can enlist personnel from any department relevant to a specific quality issue. 

 

According to Tee Noland, President & CEO of Pharma Tech: "F.I.R.S.T. allows Pharma Tech to further fulfill its promise of providing the best possible experience to its customers.   This team empowers key personnel to effectively fast-track any quality control issue by expediting the key steps, which include segregation of the product, realization of the issue, and restarting production as quickly as possible.  From there, processes are reviewed and discussed in order to continuously improve protocol for quality control and oversight."

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

PHARMA TECH HELPS

 GLOBAL PHARMACEUTICAL CUSTOMER MAINTAIN SUPPLY OF KEY PRODUCT 

Pharma Tech recently began production trials on a prescription product that treats the symptoms for dry mouth disorder for a key global pharmaceutical customer.  This product, currently in the marketplace, was being produced at another suppler that was having consistent supply challenges.  Pharma Tech's business development and technology transfer teams were able to quickly put together an action plan for immediate transfer into its 275,000-sq-ft cGMP facility in Royston, GA. 

 

In what could have led to an extended out of stock scenario or possible product de-listing, Pharma Tech was able to leverage current capacity offerings coupled with custom build-out offerings to keep the product's supply chain in operation, thereby allowing its customer to fulfill its promises to consumers. 

 

http://img.constantcontact.com/letters/images/sys/S.gif

http://img.constantcontact.com/letters/images/sys/S.gif

COMPANY SPOTLIGHT

http://img.constantcontact.com/letters/images/sys/S.gif

 

http://files.constantcontact.com/6af9cff2101/ab4ffdb7-a7a4-4dd7-8d2d-820dd7b54e03.jpg

 

PHARMA TECH

 WELCOMES ERIC KANEPS AS VICE PRESIDENT OF BUSINESS DEVELOPMENT

Eric Kaneps has been named Vice President of Business Development. In this role, his primary responsibility is developing and maintaining new supply chain relationships with both current and potential customers.  

 

Eric has spent the last 23 years in sales and business development serving the pharmaceutical and consumer healthcare markets. Most recently, he was Director of Business Development for DPT Labs and, before that, Global Account Manager for Alcan Flexible Packaging. 

 

"Eric's business development and supply chain solutions experience will help Pharma Tech continue its growth trend," said Tee Noland, Chairman & CEO of Pharma Tech Industries.  "His proven ability to develop and maintain strong customer relationships will be invaluable as we build upon our excellent record of exemplary quality, expedient turnaround, and overall customer satisfaction."

 

Eric has a BSBA in Economics and International Business Administration from The Ohio State University.

http://img.constantcontact.com/letters/images/sys/S.gif

SHOWS & EVENTS

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

http://files.constantcontact.com/6af9cff2101/822cd11a-0334-46c7-b1e3-7e20ebc2d42b.png

 

CHPA Market Exchange

 

September 14-15, 2016

Hyatt Regency Hotel

Princeton NJ

 

http://files.constantcontact.com/6af9cff2101/8678b182-d9ba-4482-a93f-33102334e457.png

 

Contract Pharma's Contracting and Outsourcing Conference

  

September 22 - 23, 2016

Hyatt Regency Hotel

New Brunswick, NJ 

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

http://img.constantcontact.com/letters/images/sys/S.gif

 

http://files.constantcontact.com/6af9cff2101/46aacc5d-86cf-47d9-8680-947a2101725f.jpg

 

We make products that fulfill promises


Pharma Tech Industries
| 272 West Hancock Avenue | Suite 300D | Athens | GA | 30601